Cadence Capital Management’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
Other funds holding NEO
EAM
CTA
EA
EMFAT
GIP
Cadence Capital Management's NEO Position: Q2 2019 in Review
Cadence Capital Management sold out of NeoGenomics (NEO) in Q2 2019, closing a stake of 132,414 shares — an estimated $2.71M sold.
Cadence Capital Management first reported a position in NEO in Q3 2014 and held it in 14 quarters. The position peaked at $2.71M in Q1 2019. 253 funds tracked by Wall St. Rank hold NEO as of Q2 2019.
- Cadence Capital Management reported no remaining NeoGenomics position as of Q2 2019 after selling out during the quarter.
- Cadence Capital Management sold 132,414 NeoGenomics shares in Q2 2019, an estimated $2.71M.
- Cadence Capital Management first reported a position in NeoGenomics in Q3 2014 and held it in 14 quarters.
- Cadence Capital Management's NeoGenomics position peaked at $2.71M in Q1 2019.
- 253 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2019.
Based on Cadence Capital Management's 13F filing for Q2 2019, filed 12 Aug 2019.